J. Safra Sarasin Holding’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.89M	Sell	14,996 -1,439	-9%	-$469K	0.08%	135
2025 Q1	$4.44M	Sell	16,435 -2,707	-14%	-$731K	0.08%	140
2024 Q4	$4.5M	Buy	19,142 +7,868	+70%	+$1.85M	0.08%	143
2024 Q3	$3.1M	Buy	11,274 +4,403	+64%	+$1.21M	0.05%	171
2024 Q2	$1.67M	Buy	+6,871	New	+$1.67M	0.03%	243